[Impact of an intervention to improve the vaccination coverage against in hiv patients].

Ignacio Hern��ndez-Garc��a, Francisco Rom��n-Calder��n, H��ctor L��pez-Mendoza, Carlos Aibar-Rem��n, Grupo de Trabajo en vacunas HCULB
Author Information
  1. Ignacio Hern��ndez-Garc��a: Servicio de Medicina Preventiva y Salud P��blica. Hospital Cl��nico Universitario Lozano Blesa. Zaragoza. Espa��a.
  2. Francisco Rom��n-Calder��n: Servicio de Medicina Preventiva y Salud P��blica. Hospital Cl��nico Universitario Lozano Blesa. Zaragoza. Espa��a.
  3. H��ctor L��pez-Mendoza: Servicio de Medicina Preventiva y Salud P��blica. Hospital Cl��nico Universitario Lozano Blesa. Zaragoza. Espa��a.
  4. Carlos Aibar-Rem��n: Servicio de Medicina Preventiva y Salud P��blica. Hospital Cl��nico Universitario Lozano Blesa. Zaragoza. Espa��a.

Abstract

OBJECTIVE: People affected by the human immunodeficiency virus (HIV) have a higher risk of invasive pneumococcal disease. Therefore, vaccination against streptococcus pneumoniae is recommended for that group. The objective of this study was to analyze the impact of implementing a hospital appointment to assess vaccination status as part of the vaccination schedule of HIV patients.
METHODS: We carried out a quasi-experimental uncontrolled before and after study with a sampling of consecutive cases of HIV patients referred to our department from November 1, 2014 to June 30, 2018. The study compared the vaccination coverage on the date of the appointment for an assessment of their vaccination status in our department and after the appointment. The analysis used the chi-squared test and the values on the date of the first appointment were taken as a reference.
RESULTS: 209 patients were analyzed, and a statistically significant improvement was observed regarding their vaccination coverage: 2.9% of the patients had been vaccinated on the date in which they made an appointment for assessment by our department, and 88.0% were vaccinated after they left (OR [95%CI]: 30.7 [13.92-67.58]) with the 13-valent pneumococcal conjugate vaccine; and 16.3% had been vaccinated on the date they made the first appointment vs. 83.7% after they came to the appointment (OR [95%CI]: 5.2 [3.76-7.04]) with the 23-valent polysaccharide pneumococcal vaccine.
CONCLUSIONS: Implementing a hospital appointment for vaccination is an effective intervention to improve vaccination coverage against streptococcus pneumoniae in HIV patients.

Keywords

References

  1. PLoS One. 2019 Aug 8;14(8):e0220848 [PMID: 31393931]
  2. Reumatol Clin (Engl Ed). 2020 Mar - Apr;16(2 Pt 1):97-102 [PMID: 29752214]
  3. Vaccine. 2015 Jun 22;33(28):3159-60 [PMID: 25128803]
  4. J Am Med Inform Assoc. 2006 Jan-Feb;13(1):16-23 [PMID: 16221933]
  5. Acta Otorrinolaringol Esp (Engl Ed). 2019 Nov - Dec;70(6):336-341 [PMID: 30579509]
  6. BMC Health Serv Res. 2016 May 13;16:182 [PMID: 27177430]
  7. Lancet Infect Dis. 2014 Jul;14(7):600-8 [PMID: 24932893]
  8. Braz J Infect Dis. 2016 Sep-Oct;20(5):487-93 [PMID: 27542868]
  9. AIDS Care. 2018 Feb;30(2):146-149 [PMID: 29052434]
  10. Sex Health. 2012 Nov;9(5):495-6 [PMID: 22950965]
  11. Clin Infect Dis. 2020 Jun 24;71(1):41-50 [PMID: 31634398]
  12. J Healthc Qual Res. 2018 Mar - Apr;33(2):82-87 [PMID: 29530605]
  13. Rev Esp Quimioter. 2013 Sep;26(3):232-52 [PMID: 24080892]
  14. HIV Med. 2016 Aug;17 Suppl 3:s2-s81 [PMID: 27568789]
  15. Med Mal Infect. 2010 Dec;40(12):683-90 [PMID: 20822870]
  16. MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9 [PMID: 23051612]
  17. Hum Vaccin Immunother. 2019;15(2):295-304 [PMID: 30111224]
  18. Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78 [PMID: 11816692]
  19. Can Fam Physician. 2013 Jun;59(6):650-7 [PMID: 23766052]
  20. Rev Esp Salud Publica. 2019 Apr 22;93: [PMID: 31006771]
  21. Vaccine. 2014 Jul 31;32(35):4558-4564 [PMID: 24951870]
  22. Gac Sanit. 2015 May-Jun;29(3):235-6 [PMID: 25596809]

MeSH Term

Adult
Communicable Disease Control
Female
HIV Infections
Health Promotion
Humans
Immunization Programs
Male
Middle Aged
Patient Compliance
Pneumococcal Infections
Pneumococcal Vaccines
Spain
Streptococcus pneumoniae
Vaccination Coverage

Chemicals

13-valent pneumococcal vaccine
23-valent pneumococcal capsular polysaccharide vaccine
Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinationappointmentHIVpatientscoveragedatepneumococcalstudydepartmentvaccinatedstreptococcuspneumoniaehospitalstatus30assessmentfirst2madeOR[95%CI]:vaccineinterventionimproveOBJECTIVE:PeopleaffectedhumanimmunodeficiencyvirushigherriskinvasivediseaseThereforerecommendedgroupobjectiveanalyzeimpactimplementingassesspartscheduleMETHODS:carriedquasi-experimentaluncontrolledsamplingconsecutivecasesreferredNovember12014June2018comparedanalysisusedchi-squaredtestvaluestakenreferenceRESULTS:209analyzedstatisticallysignificantimprovementobservedregardingcoverage:9%880%left7[1392-6758]13-valentconjugate163%vs837%came5[376-704]23-valentpolysaccharideCONCLUSIONS:Implementingeffective[Impacthivpatients]PneumococcalvaccinesSpainVaccination

Similar Articles

Cited By